Evergreen Theragnostics, established in 2019, is a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) with deep expertise in theranostic radiopharmaceutical commercialization, manufacturing process development, and regulatory affairs management. In 2025, Evergreen was acquired by Lantheus, the leading radiopharmaceutical-focused company
| Website | http://evergreentgn.com |
| Revenue | $9.5 million |
| Employees | 74 (74 on RocketReach) |
| Founded | 2019 |
| Address | 27 Commerce St, Springfield, New Jersey 08041, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+14 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Drug Discovery |
| Keywords | Radiopharmaceutical Development, Targeted Therapy, Cdmo Services, Radiopharmaceutical Manufacturing, Radioisotopes, Contract Manufacturing, Pharmaceutical Cdmo, Nuclear Medicine, Molecular Imaging, Contract Development, Drug Development, Pharmaceutical Manufacturing, Diagnostic Imaging, Clinical Trial Materials, Drug Manufacturing, Drug Production |
| Competitors | Novartis, Cardinal Health, GE HealthCare, Siemens Healthineers, Bracco, Lantheus, Sun Nuclear, Avid Radiopharmaceuticals, FluoroPharma Medical Inc., CrossBridge Health +29 more (view full list) |
Looking for a particular Evergreen Theragnostics employee's phone or email?
Evergreen Theragnostics Questions
The Evergreen Theragnostics annual revenue was $9.5 million in 2026.
James Cook is the CEO of Evergreen Theragnostics.
74 people are employed at Evergreen Theragnostics.
Evergreen Theragnostics is based in Springfield, New Jersey.
Top Evergreen Theragnostics Employees
-
James Cook
Chief Executive Officer at Evergreen Theragnostics
New York, NY, US11 -
25+
-
Michael Patrick
Head of Quality at Evergreen Theragnostics
Old Bridge Township, NJ, US13
